
    
      Title: A Pilot Randomized Controlled Trial for Feasibility of Enrolling Subjects for
      Influenza Therapeutic Trials and Administering Influenza Antivirals in the Emergency
      Department to High Risk Subjects

      Population: Adults presenting to the emergency department (ED) with laboratory confirmed
      influenza who meet Centers for Disease Control and Prevention (CDC) criteria for antiviral
      treatment

      Informed consent: Written informed consent

      Number of Sites: 2 - large, urban, academically-affiliated, US EDs

      Study Duration: November 2015 - June 2018

      Subject Participation Duration: 4 weeks

      Description of Agent or Intervention: Subjects will be randomized to either oral
      (oseltamivir) or intravenous (IV) (peramivir) antiviral treatment.

      Description of Study Design: This is an open-label randomized controlled clinical trial in
      which subjects with influenza are randomized to either oral (oseltamivir) or IV (peramivir)
      antiviral treatment.

      Estimated Time to Complete Enrollment: Subject enrollment will occur over two influenza
      seasons (November 2015 - April 2016 and November 2016 - April 2017) or longer, at the
      Principal Investigator's discretion, based on influenza prevalence.
    
  